Catalyst Wire Dossier Catalyst Wire Dossier

Atmeg

atorvastatin and omega-3 fatty acids
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atmeg, covering 2024-05-01 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia [Phase 4]

See pricing